{"title":"对“Guselkumab成功治疗坏疽性脓皮病”的更正","authors":"","doi":"10.1002/jvc2.70031","DOIUrl":null,"url":null,"abstract":"<p>S. Botvid, C. Zachariae, Skov, L., and J. Ferløv Schwensen. “Successful Treatment of Pyoderma Gangrenosum With Guselkumab.” <i>JEADV Clinical Practice</i> 4, no. 1 (2025): 229. https://doi.org/10.1002/jvc2.522</p><p>Under the subheading “Case Report” of Case 1, line 8–9, the current text states: “Starting in November 2022, the patient was treated with injections (off-label) of guselkumab 400 mg, every sixth week.”</p><p>However, the correct dosage should be “<b>100 mg,</b> every sixth week” rather than 400 mg.</p><p>We sincerely apologize for this error.</p>","PeriodicalId":94325,"journal":{"name":"JEADV clinical practice","volume":"4 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jvc2.70031","citationCount":"0","resultStr":"{\"title\":\"Correction to “Successful Treatment of Pyoderma Gangrenosum With Guselkumab”\",\"authors\":\"\",\"doi\":\"10.1002/jvc2.70031\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>S. Botvid, C. Zachariae, Skov, L., and J. Ferløv Schwensen. “Successful Treatment of Pyoderma Gangrenosum With Guselkumab.” <i>JEADV Clinical Practice</i> 4, no. 1 (2025): 229. https://doi.org/10.1002/jvc2.522</p><p>Under the subheading “Case Report” of Case 1, line 8–9, the current text states: “Starting in November 2022, the patient was treated with injections (off-label) of guselkumab 400 mg, every sixth week.”</p><p>However, the correct dosage should be “<b>100 mg,</b> every sixth week” rather than 400 mg.</p><p>We sincerely apologize for this error.</p>\",\"PeriodicalId\":94325,\"journal\":{\"name\":\"JEADV clinical practice\",\"volume\":\"4 2\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-03-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jvc2.70031\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JEADV clinical practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/jvc2.70031\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JEADV clinical practice","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jvc2.70031","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
S. Botvid， C. Zachariae, Skov， L. Ferløv Schwensen。Guselkumab成功治疗坏疽性脓皮病《JEADV临床实践》第4期。1(2025): 229。https://doi.org/10.1002/jvc2.522Under病例1的副标题“病例报告”，第8-9行，当前文本指出：“从2022年11月开始，患者接受注射（标签外）400 mg的guselkumab治疗，每六周一次。”然而，正确的剂量应该是“每六周100毫克”，而不是400毫克。我们真诚地为这个错误道歉。
Correction to “Successful Treatment of Pyoderma Gangrenosum With Guselkumab”
S. Botvid, C. Zachariae, Skov, L., and J. Ferløv Schwensen. “Successful Treatment of Pyoderma Gangrenosum With Guselkumab.” JEADV Clinical Practice 4, no. 1 (2025): 229. https://doi.org/10.1002/jvc2.522
Under the subheading “Case Report” of Case 1, line 8–9, the current text states: “Starting in November 2022, the patient was treated with injections (off-label) of guselkumab 400 mg, every sixth week.”
However, the correct dosage should be “100 mg, every sixth week” rather than 400 mg.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
